{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Endometrial cancer", "Immune checkpoint inhibitor", "Immune-related adverse events", "Meningitis", "Pembrolizumab"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34926766", "DateRevised": {"Year": "2024", "Month": "04", "Day": "04"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "10", "Day": "23"}], "ELocationID": ["100885", "10.1016/j.gore.2021.100885"], "Journal": {"ISSN": "2352-5789", "JournalIssue": {"Volume": "38", "PubDate": {"Year": "2021", "Month": "Nov"}}, "Title": "Gynecologic oncology reports", "ISOAbbreviation": "Gynecol Oncol Rep"}, "ArticleTitle": "A case of relapsing aseptic meningitis under excellent tumor response to pembrolizumab in microsatellite instability-high recurrent endometrial cancer.", "Pagination": {"StartPage": "100885", "MedlinePgn": "100885"}, "Abstract": {"AbstractText": ["\u2022This is the first report of aseptic meningitis due to immune checkpoint inhibitor treatment in endometrial cancer.\u2022The meningitis was severe and relapsed multiple times unlike in other reported cases.\u2022Oncologic outcome was excellent after overcoming this severe adverse event."], "CopyrightInformation": "\u00a9 2021 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan."}], "LastName": "Noguchi", "ForeName": "Daito", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan."}], "LastName": "Seki", "ForeName": "Toshiyuki", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan."}], "LastName": "Kubonoya", "ForeName": "Yutaro", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan."}], "LastName": "Komazaki", "ForeName": "Hiromi", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan."}], "LastName": "Ozone", "ForeName": "Hirokazu", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan."}], "LastName": "Yanaihara", "ForeName": "Nozomu", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan."}], "LastName": "Takano", "ForeName": "Hirokuni", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan."}], "LastName": "Okamoto", "ForeName": "Aikou", "Initials": "A"}], "PublicationTypeList": ["Case Reports"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Gynecol Oncol Rep", "NlmUniqueID": "101652231", "ISSNLinking": "2352-5789"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bonneville R., Krook M.A., Kautto E.A., Miya J., Wing M.R., Chen H.-Z., Reeser J.W., Yu L., Roychowdhury S. Landscape of Microsatellite Instability Across 39 Cancer Types. JCO Precis. Oncol. 2017;(1):1\u201315. doi: 10.1200/PO.17.00073.", "ArticleIdList": ["10.1200/PO.17.00073", "PMC5972025", "29850653"]}, {"Citation": "Centanni M., Moes D.J.A.R., Troc\u00f3niz I.F., Ciccolini J., van Hasselt J.G.C. Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors. Clin. Pharmacokinet. 2019;58(7):835\u2013857. doi: 10.1007/s40262-019-00748-2.", "ArticleIdList": ["10.1007/s40262-019-00748-2", "PMC6584248", "30815848"]}, {"Citation": "Cuzzubbo S., Javeri F., Tissier M., Roumi A., Barlog C., Doridam J., Lebbe C., Belin C., Ursu R., Carpentier A.F. Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature. Eur. J. Cancer. 2017;73:1\u20138. doi: 10.1016/j.ejca.2016.12.001.", "ArticleIdList": ["10.1016/j.ejca.2016.12.001", "28064139"]}, {"Citation": "Johannesdottir S.A., Horv\u00e1th-Puh\u00f3 E., Dekkers O.M., Cannegieter S.C., J\u00f8rgensen J.O.L., Ehrenstein V., Vandenbroucke J.P., Pedersen L., S\u00f8rensen H.T. Use of Glucocorticoids and Risk of Venous Thromboembolism: A Nationwide Population-Based Case-Control Study. JAMA Intern. Med. 2013;173(9):743. doi: 10.1001/jamainternmed.2013.122.", "ArticleIdList": ["10.1001/jamainternmed.2013.122", "23546607"]}, {"Citation": "Nagao S., Nishio S., Michimae H., Tanabe H., Okada S., Otsuki T., Tanioka M., Fujiwara K., Suzuki M., Kigawa J. Applicability of the concept of \u201cplatinum sensitivity\u201d to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study. Gynecol. Oncol. 2013;131(3):567\u2013573. doi: 10.1016/j.ygyno.2013.09.021.", "ArticleIdList": ["10.1016/j.ygyno.2013.09.021", "24076450"]}, {"Citation": "National Comprehensive Cancer Network. 2021. NCCN Clinical Practice Guidelines in Oncology: Management of immunotherapy-related toxicities. Version 3. 2021. https://www.nccn.org/guidelines/guidelines-detail (accessed 25 September 2021).", "ArticleIdList": ["35390769"]}, {"Citation": "Rogado J., S\u00e1nchez-Torres J.M., Romero-Laorden N., Ballesteros A.I., Pacheco-Barcia V., Ramos-Lev\u00ed A., Arranz R., Lorenzo A., Gull\u00f3n P., Donnay O., Adrados M., Costas P., Aspa J., Alfranca A., Mond\u00e9jar R., Colomer R. Immune-related adverse events predict the therapeutic efficacy of anti\u2013PD-1 antibodies in cancer patients. Eur. J. Cancer. 2019;109:21\u201327. doi: 10.1016/j.ejca.2018.10.014.", "ArticleIdList": ["10.1016/j.ejca.2018.10.014", "30682533"]}, {"Citation": "Spain L., Walls G., Julve M., O\u2019Meara K., Schmid T., Kalaitzaki E., Turajlic S., Gore M., Rees J., Larkin J. Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature. Ann. Oncol. 2017;28(2):377\u2013385. doi: 10.1093/annonc/mdw558.", "ArticleIdList": ["10.1093/annonc/mdw558", "28426103"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "20"}, {"Year": "2021", "Month": "10", "Day": "12"}, {"Year": "2021", "Month": "10", "Day": "18"}, {"Year": "2021", "Month": "12", "Day": "20", "Hour": "6", "Minute": "21"}, {"Year": "2021", "Month": "12", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "10", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["34926766", "PMC8651784", "10.1016/j.gore.2021.100885", "S2352-5789(21)00189-2"]}}], "PubmedBookArticle": []}